Pantoprazole Arrow Generiques

Pantoprazole, the active ingredient in Pantoprazole Arrow Generiques, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid secretion and is used to treat acid‑related disorders in adults and children. GNH USA supplies Pantoprazole Arrow Generiques as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole acts on the gastric proton pump to manage conditions caused by excess stomach acid.

Gastro‑esophageal reflux disease (GERD): reduces acid exposure to heal esophageal irritation. Erosive esophagitis: promotes healing of acid‑induced esophageal lesions. Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid. NSAID‑induced gastric ulcer: aids ulcer healing and prevents recurrence.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache - Diarrhea - Nausea - Abdominal pain - Flatulence - Constipation

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Clostridioides difficile‑associated diarrhea - Low magnesium levels (hypomagnesemia) - Elevated liver enzymes - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Interstitial nephritis

Before initiating therapy, consider the following safety measures. - Assess renal function: adjust use in severe impairment. - Monitor magnesium levels: prolonged therapy may cause deficiency. - Avoid in known hypersensitivity: discontinue if reaction occurs. - Use cautiously in pregnancy: only if benefit outweighs risk. - Review concomitant medications: potential interactions with warfarin, methotrexate, etc. - Store at ambient temperature: keep in original container, protect from moisture.

Pantoprazole may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption of atazanavir. - Methotrexate: increased toxicity risk.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR. - Digoxin: may raise serum digoxin levels. - Diazepam: potential elevation of benzodiazepine concentrations.